×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Virtual Congress 2020
Final Programme PDF
Advanced Search
14.09.2020
15.09.2020
17.09.2020
18.09.2020
19.09.2020
20.09.2020
21.09.2020
22.09.2020
23.09.2020
12.10.2020
13.10.2020
14.10.2020
15.10.2020
16.10.2020
17.10.2020
18.10.2020
Educational session
Keynote lecture
Patient advocacy session
Special session
Special symposium
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
Channel 1
10:30(1h 20m)
First-line therapy in ovarian cancer: Where do we stand and how do we move forwards?
16:10(1h 20m)
Maximising the benefit of immuno-oncology
13:45(30m)
Present and future of cancer immunotherapy
14:30(1h 20m)
Targeted treatment in 2020
12:10(1h 20m)
What other immunotherapy options are there in recurrent metastatic disease?
Channel 2
14:30(1h 20m)
Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?
16:10(1h 20m)
Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
10:30(1h 20m)
The opioid crisis
12:10(1h 20m)
Tumour heterogeneity and its influence on cancer and immune therapy responses
Channel 3
12:10(1h 20m)
Established and new treatments, old and new toxicities (in collaboration with MASCC)
14:30(1h 20m)
Immunotherapy in colorectal cancer: Present and future
10:30(1h 20m)
Myelodysplastic syndromes in 2020
16:10(1h 20m)
New drugs in development: What will be approved in 2025?
Channel 4
10:30(1h 20m)
Challenges in managing an aging population of patients with cancer (in collaboration with SIOG)
16:10(1h 20m)
How can we reduce cancer numbers? (in collaboration with ASCO)
12:10(1h 20m)
How to run clinical trials and survive your CRO
14:30(1h 20m)
Research in AYA with cancer: Age-specific challenges and ways forward
Channel 5
14:30(1h 20m)
Future needs and techniques in oncology research
12:10(1h 20m)
Precision medicine: Hopes and hypes
16:10(1h 20m)
Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
10:30(1h 20m)
Survivorship is not survivorship without quality of life
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events